Post-transfusion acute graft versus host disease in a 17-year-old girl with a malignant mesenchymal tumor--report of a case.
Post-transfusion graft-versus-host disease (PT-GVHD) is seldom, but it has a high mortality rate, exceeding 90 percent. There is no standard treatment for PT-GVHD and irradiation of blood and its components before transfusion is broadly accepted for the prevention of PT-GVHD. In this report we present a case (a 17-year-old female) of PT GVHD, who died in spite of the use of all available therapeutic options.
Utkan
G
G
Department of Medical Oncology, Ankara University School of Medicine, Ibni Sina Hospital, 06100 Sihhiye, Ankara, Turkey. gungorutkan_md@hotmail.com
Buyukcelik
A
A
Demir
O
O
Sanli
H
H
Pamir
A
A
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D017707:Erythrocyte Transfusion / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006086:Graft vs Host Disease / Q000175:diagnosis*; D006801:Humans; D008637:Mesenchymoma / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D012008:Recurrence